XtalPi Holdings Ltd
2228.HKHKSEHealthcareBiotechnology
Latest quote
HK$7.375
−HK$0.335 · -4.35%
2228.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteXtalPi Holdings Limited functions as an investment holding company, delivering sophisticated drug discovery and intelligent automation solutions across key markets including China, the United States, Europe, South Korea, and Japan. Its comprehensive drug discovery services encompass the entire research and development process, ranging from target validation and hit identification to lead generation, lead optimization, and PCC nomination. These services are adept across diverse therapeutic modalities, such as small molecules, antibodies, peptides, ADCs, and PROTACs. The company's intelligent automation solutions specifically utilize artificial intelligence and automation to facilitate the accelerated discovery and research of novel drugs and materials. Established in 2015 and based in Shenzhen, China, the firm was formerly known as QuantumPharm Inc. before officially changing its name to XtalPi Holdings Limited in December 2024.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Jian Ma
- Listed since
- Jun 13, 2024
- Employees
- 1,254
Market position
Day range
Current HK$7.375
52-week range
Current HK$7.375
- Open
- HK$7.86
- Previous close
- HK$7.71
- Volume
- 46.54M
- 0.76× average
- Average volume
- 61.39M
- Average daily volume
- Market cap
- 31.74B HKD
- Beta
- 1.32
- Market reference 1
- 50-day average
- HK$7.3645
- +0.14% above average
- 200-day average
- HK$9.3561
- -21.17% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 29.99B CNY
- P/E (TTM)
- -122.9×
- P/B (TTM)
- 2.87×
- P/S (TTM)
- 40.72×
- EV / EBITDA
- 118.26×
- Earnings yield
- 0.38%
- Free cash flow yield
- -0.62%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 51.52%
- Operating margin
- -129.13%
- Net margin
- -31.12%
- Return on equity
- 1.28%
- Return on assets
- 1.18%
- Return on invested capital
- -4.98%
Financial health
- Debt / equity
- 0.32×
- Current ratio
- 14.77×
- Altman Z-score
- 4.38
- Piotroski F-score
- 2 of 9
Earnings
- Latest EPS result
- -0.07
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
2228.HK peers
ETFs holding 2228.HK
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Total International Stock ETFVXUS46.27M0.01%646.2B USD0.05%$87.16-0.63%
Vanguard FTSE Emerging Markets ETFVWO44.63M0.03%162.3B USD0.06%$59.915-0.89%
iShares Core MSCI Emerging Markets ETFIEMG18.96M0.01%160B USD0.09%$80.415-1.42%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS12.22M0.08%13.6B USD0.06%$159.53-0.33%
Global X China Biotech ETF (HKD)2820.HK10.46M1.72%701.08M HKD0.68%HK$73.30-4.18%
iShares MSCI Emerging Markets ETFEEM4.3M0.01%31.22B USD0.72%$66.025-1.63%
iShares MSCI China ETFMCHI4.03M0.06%6.29B USD0.59%$54.985-1.21%
Vanguard Total World Stock ETFVT2.66M0.00%97.9B USD0.06%$160.11-0.41%Vanguard Total International Stock ETFVXUS- Market value
- 46.27M
- Weight
- 0.01%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.16-0.63%
Vanguard FTSE Emerging Markets ETFVWO- Market value
- 44.63M
- Weight
- 0.03%
- AUM
- 162.3B USD
- Expense ratio
- 0.06%
- Price / 1D
- $59.915-0.89%
iShares Core MSCI Emerging Markets ETFIEMG- Market value
- 18.96M
- Weight
- 0.01%
- AUM
- 160B USD
- Expense ratio
- 0.09%
- Price / 1D
- $80.415-1.42%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS- Market value
- 12.22M
- Weight
- 0.08%
- AUM
- 13.6B USD
- Expense ratio
- 0.06%
- Price / 1D
- $159.53-0.33%
Global X China Biotech ETF (HKD)2820.HK- Market value
- 10.46M
- Weight
- 1.72%
- AUM
- 701.08M HKD
- Expense ratio
- 0.68%
- Price / 1D
- HK$73.30-4.18%
iShares MSCI Emerging Markets ETFEEM- Market value
- 4.3M
- Weight
- 0.01%
- AUM
- 31.22B USD
- Expense ratio
- 0.72%
- Price / 1D
- $66.025-1.63%
iShares MSCI China ETFMCHI- Market value
- 4.03M
- Weight
- 0.06%
- AUM
- 6.29B USD
- Expense ratio
- 0.59%
- Price / 1D
- $54.985-1.21%
Vanguard Total World Stock ETFVT- Market value
- 2.66M
- Weight
- 0.00%
- AUM
- 97.9B USD
- Expense ratio
- 0.06%
- Price / 1D
- $160.11-0.41%
Continue in GoAI
Research 2228.HKresearch.disclaimer